Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “TCP”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 991 records · Page 55Linked to original sources

Removal of phenol and chlorophenols from water by coir pith carbon: equilibrium and rate studies.

Batch mode studies were conducted to study the removal of phenol, 2,4,6-Trichlorophenol (TCP) and Pentachlorophenol (PCP) from aqueous solution on coir pith carbon by adsorption process under varying experimental conditions such as agitation time, adsorbent dose, pH and temperature. Kinetics of adsorption obeyed second order rate equation and the rate constant was found to be in the range 0.0098-0.0672, 0.0949-0.8801 and 0.172-0.305 g/mg/min for phenol, TCP and PCP respectively. Equilibrium adsorption data follow Langmuir isotherm for phenol and PCP and the adsorption capacities were found to be 48.3 mg and 3.7 mg/g, respectively. For TCP, adsorption followed Freundlich isotherm only. Acidic pH was favorable for the adsorption of all the chlorophenols. Studies on pH effect and desorption show that chemisorption seems to play a major rule in the adsorption process. The positive values of H0 24.99, 18.69, and 8.907 kJ/mol for phenol, TCP and PCP respectively, confirm the endothermic nature of adsorption.

Adsorption↗

rhPDGF-BB promotes healing of periodontal defects: 24-month clinical and radiographic observations.

A new therapeutic system using purified recombinant human platelet-derived growth factor-BB (rhPDGF-BB) in combination with a biocompatible, osteoconductive, synthetic scaffold beta-tricalcium phosphate (beta-TCP) has recently been shown in a large-scale, prospective, blinded, randomized clinical trial to safely and effectively treat advanced periodontal osseous defects. A significant gain in clinical attachment level was observed 3 months postsurgery for sites treated with 0.3 mg/mL rhPDGF-BB + beta-TCP versus beta-TCP + buffer (active control), with this trend continuing at 6 months postsurgery. Additionally, sites treated with 0.3 mg/mL rhPDGF-BB + beta-TCP also had significantly greater radiographic linear bone gain and percent defect fill at 6 months postsurgery than sites that received bone substitute with buffer. Representative cases from the clinical trial were followed to assess their ability to maintain the initial effect of treatment observed at 6 months. At 18 or 24 months postsurgery, with the same clinical and radiographic measurement techniques used as were performed at the 6-month time point for the clinical trial, these cases demonstrated maintenance of the clinical attachment level for all but one case, with all cases demonstrating substantial increases in linear bone gain and percent bone fill versus measurements obtained at 6 months postsurgery. Substantial radiographic changes in the appearance of the defect fill were observed for both rhPDGF-BB treatment groups, consisting of increased radiopacity and bone trabeculation, indicative of increased mineralization and maturation of the bone observed 6 months postsurgery.

Adult↗

[A study on alpha-tricalcium phosphate bone cement carbon fiber-reinforced].

In order to improve the mechanical properties of alpha-tricalcium phosphate (alpha-TCP), we prepared surface-modified carbon fibers (CF) reinforced alpha-TCP composite bone cement. Bone cement was soaked in Ringer's body solution to test its capacity of fast formation of hydroxyapatite crystals and self-solidification. Scan electronic microscope (SEM) observation and compressive strength measurement were taken to analyze the mechanical properties and the micro- morphological structure of CF reinforced alpha-TCP bone cement. The results showed that the bone cement was transferred into hydroxyapatite plates after being soaked in Ringer's simulated body fluid for 5 days. Suitable amount of carbon fibers could well spread in and bond with the matrix of the bone cement. The mechanical properties of the bone cement have been improved by CF reinforcing; the compressive strength reaches 46.7 MPa when the amount of carbon fibers is 0.5% in weight percent, which is 22% higher than that of the non-reinforced alpha-TCP bone cement.

Bone Cements↗

[Perfusion-weighted magnetic resonance imaging for monitoring vascularization in tissue-engineered bone in rhesuses].

OBJECTIVE: To assess the value of perfusion-weighted magnetic resonance (MR) imaging (PWMRI) in monitoring vascularization in tissue-engineered bone graft. METHODS: Tibial diaphyseal defect of 20 mm was induced in 25 lower limbs of 13 rhesuses and fixed with an AO reconstruction plate with 7 holes. The monkeys were randomized into 5 groups according to the materials used for defect filling: group A, with beta-tricalcium phosphate (beta-TCP), bone marrow stromal cells (BMSCs) and blood vessel bundles; group B, with beta-TCP and blood vessel bundles; group C, with beta-TCP and BMSCs; group D, with beta-TCP, and group E without filling. PWMRI, X-ray, and radionuclide imaging were carried out at weeks 4, 8, 12 postoperatively. The maximum slope rates of the single intensity-time curve (SS(max)) and the baseline values (SI(baseline)) on the same time points were calculated. Transmittances on the X-ray films and isotope counts in the region of interest (ROI) were assessed and calculated. RESULTS: Compared with other groups, group A showed the highest SS(max) at weeks 4, 8, and 12 postoperatively, and its SS(max) at week 8 was significantly higher than that at week 4 (P=0.003). The SS(max) was positively related to isotope counts in ROI at week 8 after operation (r(s)=0.899, P=0.038), and inversely related to transmittance on X-ray films at week 12 (r(s)=-0.892, P=0.042). CONCLUSION: The SS(max) of the single intensity-time curve can accurately reflect the vascularization of the tissue-engineered bone graft, and PWMRI allows sensitive, quantitative, noninvasive and radiation-free vascularization monitoring.

Animals↗

Beta-tricalcium phosphate as a synthetic cancellous bone graft in veterinary orthopaedics: a retrospective study of 13 clinical cases.

The clinical use of beta-tricalcium phosphate (beta-TCP) as a synthetic cancellous bone graft in veterinary orthopaedics is herein reported. The retrospective study was based on 13 clinical cases belonging to 11 dogs and one cat. The weights of the dogs ranged from 3.4 to 48 kg. One female cat weighing 3.5 kg completed the study. The clinical cases were six arthrodeses (four carpal, two tarsal), one hypertrophic non-union (femur), one atrophic non-union (metacarpal bones) and five long-bone fractures (two femurs, one tibia, two radii) possessing subcritical-sized bone defects. The beta-TCP used in this study was presented as irregular interconnected- porous granules and was placed in the bone defects after mixing it with fresh blood. Bone healing was achieved at between eight and 12 weeks in all clinical cases except for the case of the chronic atrophic nonunion in which only one of the four metacarpal bones healed. In the 12 successful cases, the bone defect grafted with beta-TCP showed a radiological bone ingrowth of 100% (10 cases), 90% (one case) and 75% (one case). The complete lack of tissue adverse effects in our series, and the good defect healing, allows us to hypothesise that beta-TCP can be successfully used as a synthetic bone graft in bone defects with good local biological conditions and where osteoconduction is especially needed for assuring a structural scaffold for new-bone ingrowth. When, in addition to osteoconduction, osteoinduction and osteogenesis are necessary for defect healing, the fresh cancellous bone graft remains the gold standard in veterinary orthopaedics.

Animals↗

In vitro release of azidothymidine (AZT) by ceramic drug delivery systems.

Conventional methods of administration of 3-azido-2,3-dideoxythymidine (AZT) to treat AIDS patients is associated with negative side effects, including toxic effects on bone marrow. This study was designed to investigate the capability of tricalcium phosphate (TCP) and alumino-calcium-phosphorous oxide (ALCAP) drug delivery systems to release AZT in a sustained manner in an in vitro environment. A total of 35 TCP and 35 ALCAP ceramic capsules were used in this experiment. The final densities of the ceramics were 1.68 +/- 0.11 and 1.58 +/- 0.08 g/cm3 for ALCAP and TCP, respectively. Tricalcium phosphate ceramics were distributed into four groups. Each ceramic in groups I, II and III (n = 10) was loaded with 20, 40, or 60 mg of AZT in powder form, respectively. Group IV ceramics (n = 5) were left empty and served as a control group for possible corrections of absorbance readings. A similar protocol was followed for ALCAP ceramic capsules unless otherwise indicated. All TCP and ALCAP ceramic capsules were sealed at both ends with Silastic Medical Adhesive Silicon Type A (Dow Corning, Midland, MI). Each empty capsule and those loaded with AZT were sealed and suspended in a capped and sealed individual serum bottles containing 100 mls of phosphate buffered saline (pH 7.4), and agitated at 100 cycles per min in a water bath at 37 degrees C. The amount of AZT released from the ceramic reservoir into the buffered medium was measured spectrophotometrically (265 nm). Release of AZT from the ceramic capsule was monitored until the contents of the capsules were depleted.(ABSTRACT TRUNCATED AT 250 WORDS)

Aluminum Oxide↗

Differential effects of tranylcypromine and imidazole on mammary carcinogenesis in rats fed low and high fat diets.

Neoplastic development in the rat mammary gland can be suppressed by inhibition of the activity of several enzymes involved in eicosanoid biosynthesis. In order to investigate the potential utility of prostacyclin and thromboxane synthetases as targets for mammary cancer chemoprevention, experiments were conducted to determine the influence of tranylcypromine (TCP), an inhibitor of prostacyclin synthetase, and imidazole (IMI), an inhibitor of thromboxane synthetase, on mammary carcinogenesis induced in rats by N-methyl-N-nitrosourea. Fifty-day-old female Sprague-Dawley [Hsd:SD(BR)] rats received a single s.c. dose of 0 or 40 mg of N-methyl-N-nitrosourea per kg of body weight. Beginning 7 days after carcinogen administration, groups of rats were fed isoenergetic, casein-based diets containing 3 or 20% corn oil (w/w), supplemented with (per kg of diet) 10 mg of TCP, 1000 mg of IMI, or sucrose carrier only. TCP reduced mammary carcinoma multiplicity in rats fed the 20% corn oil diet, but had no effect in rats fed the diet containing 3% fat. By contrast, supplementation with IMI increased mammary cancer incidence in the group fed the 20% fat diet and increased carcinoma multiplicity in the 3% fat group to the levels seen in rats fed the 20% fat diet. These data suggest that inhibition of prostacyclin synthetase, but not thromboxane synthetase, may present a useful mechanism for mammary cancer chemoprevention in animals consuming a diet high in fat. Furthermore, the differential effects of TCP and IMI in rats fed low and high fat diets suggest that the action of dietary fat in mammary cancer induction may involve influences on the arachidonic acid cascade.

Animals↗

[Influence of tannic acid on physical and chemical properties of alpha-tricalcium phosphate-citric acid-tannic acid complex].

A mixture of alpha-tricalcium phosphate [alpha-Ca3(PO4)2; alpha-TCP] with a citric acid solution produces a hardened alpha-TCP-citric acid complex. The influence of tannic acid as an additive in the solution on the physical and chemical properties of the obtained complex was examined as a basic study for new calcium phosphate materials incorporating alpha-TCP. alpha-TCP was mixed with mixing liquids containing citric and tannic acids at various ratios [total acid = 45% (w/w)] at a powder/liquid = 2.2/1.0 (g/g). Compressive strength, setting time, and solubility & disintegration of the resulting complexes were measured by the methods specified by ADAS No. 61. After immersing the plates of the complexes in distilled water for 1 and 7 days, the surface structure of the plates was examined by using X-ray diffraction, scanning electron microscopy and IR spectroscopy. The substances solubilized and disintegrated in the water for 1 day were also examined by measuring quantitative Ca and P concentration. When the ratio of tannic acid to total acids (T/A) was higher than 30% (w/w), both setting time and solubility & disintegration increased remarkably. In the case of the complex at T/A = 30%, both setting time and solubility & disintegration showed the minimum value (6.25 min and 1.70%). For compressive strength, the maximum value (139 MPa) was obtained at T/A = 10%. Although the strength decreased markedly with increasing T/A beyond 10%, that of the complex at T/A = 30% was still a high level (103 MPa). The products on the surfaces before and after immersing the plates in distilled water were also discussed.

Calcium Phosphates↗

An immunological study of tricalcium phosphate supplied by three different manufacturers.

Antigenicity of tricalcium phosphate (TCP) ceramics which were supplied by two Japanese manufacturers and a manufacturer of United States was studied by means of delayed skin reactions in guinea pigs. Skin reactions were elicited 13 days after being immunized by intradermal injection of the ceramics into the dorsal flanks of guinea pigs. After 24 and 48 hr, these reactions were assessed by measuring the diameter of the erythema, the degree of hemorrhaging and its induration. Antigenicity was not detected in the TCP obtained from the Asahi Optical Co., Ltd. and the Kyocera Corporation by means of skin reactions. In contrast, TCP from Miter, Inc. (Synthograft) raised a delayed type hypersensitivity (DTH) 24 hr after antigen elicitation. The reaction appeared to be based on tuberculin type and Jones-Mote type of reactions. Arthus reactions were not observed in either the normal groups or groups immunized with TCP.

Animals↗

[Comparative study of bioactive calcium phosphate ceramics after implantation in spongy bone in dogs. Histologic, ultrastructural and electron probe microanalysis].

An experimental model of posterior spine arthrodesis in dogs was created using 3 types of calcium phosphate biomaterials already known for their applications as bone substitutes, namely: hydroxyapatite (HA), which is not readily resorbable; highly resorbable tricalcium phosphate (TCP); and a mixture of HA and TCP (BCP), the resorbability of which depends on the proportion of HA and TCP. The BCP implants had a macroporous structure, whilst the HA and TCP implants were used in dense form. The creation of macropores increases the surface exchange area, thus enabling the osseous colonization processes. By carefully removing the posterior articular facets it was possible to remove the articular surfaces and to fit into each appropriate location a block a few millimeters in diameter. The anatomopathological assessment was performed using histological methods, transmission electron microscopy, and energy dispersion microprobe analysis. Our results indicate that calcium phosphate ceramics may be used as bone substitutes for carrying out arthrodeses, provided (1) immediate immobilization using a spine containment technique is effected; (2) their chemical composition is sufficiently stable over time; (3) they are sufficiently bioactive so as to allow their colonization and replacement by bone.

Animals↗

Ifenprodil and SL 82.0715 as cerebral anti-ischemic agents. II. Evidence for N-methyl-D-aspartate receptor antagonist properties.

The effects of the anti-ischemic agents ifenprodil and its derivative SL 82.0715 ((+/-)-alpha-(4-chlorophenyl)-4-[(4-fluorophenyl) methyl]-1-piperidineethanol] have been analyzed in a number of models indicative of N-methyl-D-aspartate (NMDA) antagonistic potential in vitro and in vivo. Ifenprodil and SL 82.0715 potently and noncompetitively antagonize the stimulatory effects of NMDA on cyclic GMP production in immature rat cerebellar slices (IC50 values, 0.4 and 10 microM, respectively), as well as the NMDA-evoked [3H]acetylcholine release in adult rat striatal slices (IC50 values, 1.6 and 6.6 microM, respectively). Ifenprodil is 10 times more potent than (+/-)3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid (CPP) but less active than the reference noncompetitive NMDA channel blockers [MK 801, ((+)-5-methyl-10,11-dihydro-5H-dibenzo-[a,d]cyclohepten-5,10-imine ], phencyclidine and 1-[1-(2-thienyl)cyclohexyl]piperidine (TCP)] in these models. Ifenprodil and SL 82.0715 partially displace (maximal displacement 40-50% at 10 microM) the NMDA receptor ligand [3H]CPP from its binding site to rat brain membranes (IC50 values, 0.1 and 0.3 microM, respectively) in a noncompetitive manner; in the micromolar range the two agents also partially displace the NMDA channel ligand [3H]TCP from its binding site to rat brain membranes, and noncompetitively antagonize the L-glutamate-induced increase in [3H]TCP binding. Ifenprodil (0.01-1 microM) partially antagonizes the depolarizing effects of NMDA on the immature rat hemisected spinal cord in vitro. In mouse cultured spinal cord neurons, ifenprodil dose-dependently antagonizes the depolarizing effects of micropressure applied NMDA. Inhibition of the effects of NMDA in this model by ifenprodil and SL 82.0715 is noncompetitive. In vivo and after systemic i.p. administration, ifenprodil and SL 82.0715 antagonize the stimulatory effects of intrastriatally dialyzed NMDA on striatal dopamine release in rats (ID50 values, 0.9 and 0.3 mg/kg, respectively), and block the harmaline-evoked increase in cerebellar cyclic GMP production in mice (ID50 values, 3 and 4 mg/kg, respectively). These results indicate that ifenprodil is a noncompetitive NMDA antagonist which has a mechanism of action distinct from either the reference competitive NMDA receptor antagonists (CPP and 2-amino-5-phosphonovalerate) or the noncompetitive NMDA channel blockers (phencyclidine, TCP and MK 801). The potent NMDA antagonistic effects of the ifenprodil class of compounds are likely to be related to the demonstrated anti-ischemic potential of these compounds.

Animals↗

[Test of 0,0-dimethyl (l-hydroxy-2,2,2-trichloroethyl)-phosphonate (trichlorfon) for carcinogenic activity in mice by oral (oesophageal-gastric intubation), intraperitoneal and dermal application (author's transl)].

0,0-Dimethyl(1-hydroxy-2,2,2-trichloroethyl)-phosphonate (Trichlorfon; TCP) was tested for carcinogenic activity in male and female mice derived from strain AB/Jena by oral (oesophageal-gastric intubation), intraperitoneal and dermal administration. The maximum period of treatment was 73 (oral), 73 (intraperitoneal) or 75 (dermal) weeks. During this period the following maximum mean total doses of TCP per animal had been administered: 157.5 mg(male, oral), 154 mg (female, oral), 160.8 mg (male, intraperitoneal), 149.7 mg (female, intraperitoneal). The dermally treated male and female mice had received a maximum total dose of 375 mg per animal. The study was terminated at 80 weeks. There is no statistic significant difference when compared the total tumour incidence of TCP-treated animals and control mice or the incidence of the different corresponding groups of mice separated by the route of administration or the incidence of malignant and benign tumours separated for the different groups. These findings were independent from whether the groups of TCP-treated animals and solvent control animals were combined or divided by sex for comparison.

Adenocarcinoma↗

Extraction and cleanup of fish, sediment, and water for determination of triaryl phosphates by gas-liquid chromatography.

Several techniques were evaluated for extracting triphenyl phosphate (TPP), 14C-labeled TPP, cresyl diphenyl phosphate, and tricresyl phosphate isomers (o-TCP, m-TCP, and p-TCP) from fish and sediment samples. Extracts of fish samples were cleaned up by gel permeation chromatography/alumina column chromatography; sediment extracts received alumina treatment only. Compounds were determined by gas-liquid chromatography (GLC) with nitrogen-phosphorus detection. Methanol/Polytron and hexane/ball mill extraction of fish samples fortified at 0.01, 0.1, and 1.0 microgram/g levels gave overall recoveries of the 5 compounds of 89 and 97%, respectively. Methanol recovered more radioactivity (97%) from fish exposed to 14C-TPP in aquaria for 24 h than did hexane from fish exposed for 16 h (79%). Refluxing fortified sediment (0.05 and 0.5 microgram/g) with methanol-water (9 + 1) gave significantly higher recoveries (88%) of the 5 triaryl phosphates than did dichloromethane-methanol (1 + 1) reflux or acetone-hexane (1 + 1) Soxhlet extraction. Recoveries of TPP and o-, m- and p-TCP from fortified river water (0.5, 5.0, and 50 microgram/L) by shaking with dichloromethane ranged from 91 to 118%. Some problems were encountered with interfering GLC peaks at low (microgram/g) levels in fish and sediment extracts despite the use of nitrogen-phosphorus specific detectors.

Animals↗

A ceramic system for continuous release of acetylsalicylic acid.

This investigation was conducted to study the release of acetylsalicylic acid (ASA) from a beta-Tricalcium Phosphate (TCP) resorbable ceramic matrix (RCM) in Tris-HCl (pH 7.4, 0.5M) at 37 degrees C. Initial compression load studies were conducted for 12 hours. Compression load and dose-response studies were conducted for a total duration of seven days. Mixtures of 150 mg acetylsalicylic acid (Aspirin) and 500 mg TCP were compressed at loads of 2000, 3000, or 4000 lbs. Ceramics with 75, 150, 225, 300, or 375 mg of ASA were mixed with 500 mg TCP and compressed at 3000 lbs. Aliquots of Tris-HCl, taken at two hour intervals for the first 12 hours, and daily thereafter, were assayed spectrophotometrically for ASA at 245 nm. Differences in the amounts of ASA released by RCMs compressed at the three loads were not significant. Release of ASA from RCMs was linear only if the ceramic/ASA ratio was close to 6.67:1. Results of this investigation suggest that resorbable TCP ceramics can be used for continuous delivery of ASA for seven days.

Aspirin↗

[Prevention and treatment of status epilepticus induced by soman].

Treatment of the convulsive and neuropathologic actions of organophosphates comprise the major unsolved problem in defending against this class of chemical nerve agents. Understanding and preventing these central actions are important goals of chemical defense research. It is generally accepted that inhibition of acetylcholinesterase results in an accumulation of acetylcholine (ACh) which may be responsible for the acute toxic effects of nerve agents. Although atropine has long been used in the treatment of poisoning, it does not significantly reduce convulsions and seizures nor does it drastically alter the acute toxicity. Inasmuch as antimuscarinic agents do not provide sufficient antidotal activity, it follows that ACh may not be the only transmitter involved in the CNS actions of organophosphates. Benzodiazepines, the most potent of the clinically available anticonvulsants are potentially useful as antidote against nerve agent poisoning. However, significant disadvantages are associated with the im administration of benzodiazepines particularly diazepam the now anticonvulsant fielded drug. The present report was undertaken to compare the effectiveness of thienyl phencyclidine (TCP), a non-competitive antagonist at N-methyl-D-aspartate (NMDA) glutamate receptors, to diazepam both administered im for protection against soman toxicity (convulsions, seizures, incidence on death, brain damage). In a first set of experiments, male wistar rats were pretreated with diazepam (1 mg/kg) given im. Fifteen minutes later 1 x LD50 of soman was injected sc and the incidence of seizures and death were recorded for 24 hr. The therapeutic efficacy of a post-poisoning treatment of diazepam was also studied. In this case diazepam was administered 45 min after the onset of seizures. In a second set of experiments, guinea-pigs were pretreated with pyridostigmine (0.2 mg/kg, sc) in combination with atropine (5 mg/kg, im) 30 min before soman (62 micrograms/kg, sc) and the protective effect of TCP (2.5 mg/kg, im) evaluated when the drug was administered either before soman (15 or 30 min) or after the onset of EEG seizures (5, 30 or 60 min). Pretreatment with diazepam alone did reduce soman-induced seizures but did not reduce mortality of rats. Neuropathology was not observed in non-seizuring rats. When given 45 min after the onset of seizures, diazepam failed to protect against status epilepticus and neuropathology. Thus, diazepam was more effective when given before, rather than after, seizure initiation. Systemic injection of TCP blocked the seizures induced by 2 x LD50 of soman in guinea-pigs pretreated by pyridostigmine and atropine. The anticonvulsant potency of TCP was particularly obvious when the compound was administered curatively.(ABSTRACT TRUNCATED AT 400 WORDS)

Animals↗

Transforming growth factor-beta 1 stimulates bone ongrowth to weight-loaded tricalcium phosphate coated implants: an experimental study in dogs.

Bone growth into cementless prosthetic components is compromised by osteoporosis, by any gap between the implant and the bone, by micromotion, and after the revision of failed prostheses. Recombinant human transforming growth factor-beta 1 (rhTGF-beta 1) has recently been shown to be a potent stimulator of bone healing and bone formation in various models in vivo. We have investigated the potential of rhTGF-beta 1, adsorbed on to weight-loaded tricalcium phosphate (TCP) coated implants, to enhance bone ongrowth and mechanical fixation. We inserted cylindrical grit-blasted titanium alloy implants bilaterally into the weight-bearing part of the medial femoral condyles of ten skeletally mature dogs. The implants were mounted on special devices which ensured stable weight-loading during each gait cycle. All implants were initially surrounded by a 0.75 mm gap and were coated with TCP ceramic. Each animal received two implants, one with 0.3 microgram rhTGF-beta 1 adsorbed on the ceramic surface and the other without growth factor. Histological analysis showed that bone ongrowth was significantly increased from 22 +/- 5.6% bone-implant contact in the control group to 36 +/- 2.9% in the rhTGF-beta 1 stimulated group, an increase of 59%. The volume of bone in the gap was increased by 16% in rhTGF-beta1-stimulated TCP-coated implants, but this difference was not significant. Mechanical push-out tests showed no difference in fixation of the implant between the two groups. Our study suggests that rhTGF-beta 1 adsorbed on TCP-ceramic-coated implants can enhance bone ongrowth.

Adsorption↗

Active immunization of rats with chicken egg thiamin carrier protein results in early embryonic loss at periimplantation stages.

Active immunization with chicken egg white thiamin carrier protein (TCP) was performed to assess the functional importance of the vitamin carrier during gestation in rats. Towards this, fertile female rats were immunized with heterologous TCP and when the circulatory titres of anti-TCP IgG were high, these animals were mated with fertile male rats. Progression of pregnancy was monitored by measuring circulatory progesterone levels. A sudden fall in the steroid hormonal levels around day 8 post coitus was observed. Histological examination of the uterine tissue sections on day 7 revealed that active immunization with TCP affected the blastocyst viability resulting in unsuccessful implantation and hence pregnancy termination.

Animals↗

[Application of porous bioceramics for a hybrid type artificial liver system].

Biocompatible porous ceramic carrier was applied for culture of rat hepatocytes. Using composit sinters of hydroxyapatite (HAP) and beta-tricalcium phosphate (TCP) as culture carriers, freshly harvested rat hepatocytes were cultured. Adhesiveness of fibroblast L-929 cells on various TCP-HAP carriers showed that the composition of 20%-TCP and 80%-HAP is the most preferable for supporting tissue cultures. Hepatocyte function was evaluated by production rates of albumin and urea and consumption rate of glucose. The time-dependent variations of the hepatocytes functions suggest that the porous TCP-HAP carrier was effective for supporting three dimensional tissue structure.

Albumins↗